Portfolio - Osage University Partners

Aerie is a clinical-stage biotechnology company that is dedicated to the discovery and development of novel treatments for glaucoma. NASDAQ: AERI

Aerovate is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. NASDQ: AVTE

AGTC is focused on the research and development of novel gene therapies utilizing AGTC's proprietary non-pathogenic adeno-associated virus (AAV) delivery system. NASDAQ: AGTC

Algorithmia’s AI Layer manages the machine learning lifecycle and automates the deployment of machine learning models at scale.

Antiva is a clinical stage biopharmaceutical company developing therapeutics for the treatment of diseases caused by Human Papilloma Virus (HPV).

Aptinyx is focused on the development of novel drugs to treat neurological disorders. NASDAQ: APTX

Ambiq Micro is a semiconductor company that has developed breakthrough technology that dramatically reduces the amount of power consumed by ICs.

Arrakis is discovering small molecule therapeutics that target RNA with a focus on neurology, oncology, and rare genetic disorders.

A cell therapy platform to prevent T-cell exhaustion through epigenetic editing and use of non-viral delivery technology.

Artizan Biosciences develops therapeutic vaccines that can eliminate disease-causing bacteria in the gut microbiome.

Atsena is a gene therapy company developing novel therapies for inherited degenerative retinal diseases with no other treatment alternatives.

Avid is developing new molecular imaging agents capable of changing the medical management of chronic human diseases. Acquired by: Eli Lilly

Beam Therapeutics is developing precision genetic medicines for serious diseases. NASDAQ: BEAM

Biohaven is a biopharmaceutical company engaged in the identification and development of clinical stage compounds. NYSE: BHVN

Blade Therapeutics is advancing novel anti-fibrotic therapies to meet important patient needs.

Body Labs collects and digitizes information related to human body shape, pose, and motion. Acquired by: Amazon

Capella Bioscience is advancing their pipeline of first-in-class mAb therapeutics in areas of high unmet medical need. NASDAQ: CNTA

Cardioxyl is a clinical stage biopharmaceutical company developing treatment therapies for cardiovascular disease. Acquired by: Bristol-Myers Squibb

Cell Design Labs is a biotherapeutics company pioneering breakthrough science to develop disruptive cell-based therapies. Acquired by: Gilead Sciences

Censys monitors all enterprise devices connected to the internet and creates security products to help corporations identify vulnerabilities.

Clarifai is a startup providing cloud services for image and video recognition.

Cleave Biosciences is developing novel therapeutics targeting the Ubiquitin-Proteosome System (UPS), a cancer cell survival mechanism.

Clinipace Worldwide is a global digital clinical research organization.

Coho is a nascent biotechnology company developing medicines within a new class of therapeutics called protein degraders.

Corelight delivers the most powerful network visibility solutions for information security professionals.

Corridor Pharmaceuticals is a platform-based pulmonary and critical care company developing novel therapeutics for elevated arginase levels.

CounterFlow AI is a startup focused on AI-driven network sensors for threat hunting.

Cyteir Therapeutics is pioneering treatments for cancer and autoimmune diseases. NASDAQ: CYT

Delfi Diagnostics is focused on detecting and locating early cancer through blood testing.

DiCE Molecules designs and develops innovative therapies in immunology for patients with debilitating disease. NASDAQ: DICE

Dracen Pharmaceuticals is developing drugs in the area of immuno-metabolism.

eFFECTOR Therapeutics is focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs). NASDAQ: EFTR

eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.

Einblick is an interactive data exploration system that provides results in sub-seconds for complex ML pipelines over large datasets.

Elementary's goal is to create assistive tools to improve human output of repetitive tasks.

Embodied is an industry leading robotics and AI company.

E-Scape Bio is focused on the discovery and development of small-molecule therapeutics to treat neurodegenerative diseases.

Escient is developing small molecules against novel class of receptors called Mrgprs.

Everactive is a leading builder of industrial IoT solutions with proprietary sensor nodes with no batteries.

Evolv Technologies' mission is to keep people and places safe through technology. NASDQ: EVLV

Faraday Pharmaceuticals is focused on developing novel therapies to treat ischemia-reperfusion injury.

Fortis is focused on the development of novel antibody-drug conjugates for oncology indications.

Gevo is dedicated to being the world leader in the development of advanced bio-fuels. NASDAQ:GEVO

Glyphic Biotechnologies is decoding the human proteome through full coverage amino acid sequencing.

Graphite Bio is a next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases. NASDAQ: GRPH

Guardant is developing diagnostics to aid the detection and treatment of cancer. NASDAQ:GH

Hack The Box is the most massively growing hacking playground and cybersecurity community in the world.

Homology is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases. NASDAQ: FIXX

Hyalex is a medical device company developing artificial cartilage.

Iconic Therapeutics is built on scientific insight and expertise in tissue factor (TF) biology.

Immune Design is developing vaccine technologies for the treatment of infectious diseases and solid cancers. NASDAQ: IMDZ

Infinite Uptime is a global industrial IoT solution provider.

Infinio provides a solution to accelerate storage performance in datacenters.

Interius is expanding the potential of cell and gene therapy by developing next generation delivery technology.

IonQ is building the world’s first commercial scale trapped ion quantum computer. NYSE: IONQ

KenSci offers a predictive risk management platform for healthcare.

Kolltan Pharmaceuticals develops therapeutic monoclonal antibodies for the treatment of cancer. Acquired by: Celldex Therapeutics

Kura Oncology is a biopharmaceutical company that creates therapeutics for patients with cancer. NASDAQ: KURA

Kymeta builds software-steerable metamaterial antennas for satellite communication links.

Landos Biopharma is focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. NASDAQ: LABP

Lastline is a leading provider of malware protection.

The first community owned genomic and health research platform.

Luxtera is a fabless Silicon Photonics company. Acquired by: Cisco Systems

MC10 uses cutting edge technology to create an intelligent, flexible platform for biometric healthcare analytics.

Medisix is developing novel applications of CAR-T therapies for use in T-cell malignancies.

Menlo Security protects organizations against cyber attacks.

Millendo is focused on developing treatments for endocrine diseases. NASDAQ: MLND

Mirna is a biotechnology company focused on the development of miRNA therapeutics. NASDAQ: MIRN

Modis Therapeutics is developing nucleoside based therapies for mitochondrial DNA depletion disorders. Acquired by: Zogenix

Neuros Medical is developing neuromodulation technology for the treatment of chronic pain.

Nocion Therapeutics is a biotechnology company developing small molecules inhibitors of neuroinflammation for cough and itch.

NuMat is leading the charge in industrial gas solutions for safety and storage with breakthrough MOF materials.

Opsys is building a LIDAR sensor for the automotive and robotics industry.

Otonomy is developing and commercializing treatments for diseases of the inner and middle ear. NASDAQ: OTIC

Palladio Biosciences is developing lixivaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD). NASDAQ: CNTA

Perceptive Automata is a machine learning and computer vision company.

Picwell provides tools to help people pick ideal health plans.

Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment. Acquired by: Gilead Sciences

PMV Pharma develops first-in-class p53 and p53 pathway modulators for the treatment of cancer. NASDAQ: PMVP

Precision BioSciences is a developer of genome editing-based products. NASDAQ: DTIL

Prime Medicine was founded to bring the promise of gene editing to patients.

Q32 Bio is developing biologic therapeutics to restore healthy immune regulation.

Quantum Circuits is developing, manufacturing, and selling the first practical and useful quantum computers based on superconducting devices.

Receptos is a biopharmaceutical company focused on immunomodulatory and metabolic therapeutics. NASDAQ: RCPT

ReCode Therapeutics is developing novel treatments for genetic lung diseases like cystic fibrosis and primary ciliary dyskinesia.

Ribon Therapeutics is pioneering the discovery and development of monoPARP inhibitors.

Sana Biotechnology is creating and delivering engineered cells as medicine for patients. NASDAQ: SANA

Satsuma Pharmaceuticals is developing best-in-class products to address the unmet needs of migraine sufferers. NASDAQ: STSA

SiFive was started by the inventors of RISC-V, a modern, open-source computer instruction set architecture.

Synthorx is developing a pipeline of Synthorin™ cytokines for activity on certain immune cells. NASDAQ: THOR

Seismos is a technology provider for the oil and gas industry.

Selecta Biosciences is a biotechnology company developing novel drugs to prevent and treat disease. NASDAQ: SELB

Sera Prognostics is developing diagnostic tests with a focus on women’s health. NASDAQ: SERA

Skytree is a big data analytics company.

SolarBridge Technologies builds and markets highly reliable solar micro-inverters. Acquired by: SunPower Corp

Spero is a biopharmaceutical company developing a pipeline of novel treatments for bacterial infections. NASDAQ: SPRO

StreetLight Data is building next generation geospatial business intelligence.

Tangent Medical is focused on the development and commercialization of IV therapy products.

Twentyeight-Seven Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases.

Urjanet is a data services company providing utility energy data to enable energy cost savings.

Vector develops launch rockets for high frequency and affordable access to Low Earth Orbit.

Developers of exo-suits designed to assist workers in physically demanding tasks.

Virdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases.

Vor Biopharma is an immuno-oncology company developing novel therapies with broad potential for treating cancer. NASDQ: VOR

Voxel8 is developing multimaterial digital manufacturing for textiles.

Our Companies

Our Companies

Our Companies

Our Companies

Our Companies

Our Companies

Our Companies

Our Companies